DOSAGE REGIMEN FOR PEGYLATED INTERFERON

• 收藏
• 分享

专利权人:

发明人:

LIN KO CHUNG,KLADE CHRISTOPH,ZAGRIJTSCHUK OLEH

申请号：

IN201717015216

公开号：

IN201717015216A

申请日:

2017.04.28

申请国别(地区):

IN

年份:

2017

代理人:

摘要：

A pegylated type I interferon for use in treating an infectious disease cancer or myeloproliferative disease in a subject in need thereof wherein a 50 to 540 µg dose of the pegylated type I interferon is administered to the subject at a regular interval for a treatment period the interval being 3 to 8 weeks.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/